0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medicinal and Food Homologous Health Product Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-30D14829
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Medicinal and Food Homologous Health Product Market Research Report 2023
BUY CHAPTERS

Global Medicinal and Food Homologous Health Product Market Research Report 2025

Code: QYRE-Auto-30D14829
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medicinal and Food Homologous Health Product Market

The global market for Medicinal and Food Homologous Health Product was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Medicinal and Food Homologous Health Product is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Medicinal and Food Homologous Health Product is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Medicinal and Food Homologous Health Product include Isabel Healthcare, Nature's Way, Beijing Tongrentang Co., Ltd., Dong-E-E-Jiao Co., Ltd., By-health Co., Ltd., Zhejiang Renzhichu Health Industry Co., Ltd., Hanguk Insam Gongsa, Shandong Gubentang Health Industry Development Group Co., Ltd., Renhe Pharmacy Co., Ltd., Ningxia Qilixiang Medlar Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medicinal and Food Homologous Health Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicinal and Food Homologous Health Product.
The Medicinal and Food Homologous Health Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medicinal and Food Homologous Health Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medicinal and Food Homologous Health Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Medicinal and Food Homologous Health Product Market Report

Report Metric Details
Report Name Medicinal and Food Homologous Health Product Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Isabel Healthcare, Nature's Way, Beijing Tongrentang Co., Ltd., Dong-E-E-Jiao Co., Ltd., By-health Co., Ltd., Zhejiang Renzhichu Health Industry Co., Ltd., Hanguk Insam Gongsa, Shandong Gubentang Health Industry Development Group Co., Ltd., Renhe Pharmacy Co., Ltd., Ningxia Qilixiang Medlar Co., Ltd., Nu Skin Enterprises
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Medicinal and Food Homologous Health Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Medicinal and Food Homologous Health Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Medicinal and Food Homologous Health Product Market report?

Ans: The main players in the Medicinal and Food Homologous Health Product Market are Isabel Healthcare, Nature's Way, Beijing Tongrentang Co., Ltd., Dong-E-E-Jiao Co., Ltd., By-health Co., Ltd., Zhejiang Renzhichu Health Industry Co., Ltd., Hanguk Insam Gongsa, Shandong Gubentang Health Industry Development Group Co., Ltd., Renhe Pharmacy Co., Ltd., Ningxia Qilixiang Medlar Co., Ltd., Nu Skin Enterprises

What are the Application segmentation covered in the Medicinal and Food Homologous Health Product Market report?

Ans: The Applications covered in the Medicinal and Food Homologous Health Product Market report are Health Maintenance, Nutritional Supplement, Heart and Brain Health, Joint Health, Others

What are the Type segmentation covered in the Medicinal and Food Homologous Health Product Market report?

Ans: The Types covered in the Medicinal and Food Homologous Health Product Market report are Oral Beauty, Liver Protection, Sleep Aid, Other Types

Recommended Reports

Health Supplements

Disease Treatments

Medicinal Foods

1 Medicinal and Food Homologous Health Product Market Overview
1.1 Product Definition
1.2 Medicinal and Food Homologous Health Product by Type
1.2.1 Global Medicinal and Food Homologous Health Product Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Beauty
1.2.3 Liver Protection
1.2.4 Sleep Aid
1.2.5 Other Types
1.3 Medicinal and Food Homologous Health Product by Application
1.3.1 Global Medicinal and Food Homologous Health Product Market Value by Application (2024 VS 2031)
1.3.2 Health Maintenance
1.3.3 Nutritional Supplement
1.3.4 Heart and Brain Health
1.3.5 Joint Health
1.3.6 Others
1.4 Global Medicinal and Food Homologous Health Product Market Size Estimates and Forecasts
1.4.1 Global Medicinal and Food Homologous Health Product Revenue 2020-2031
1.4.2 Global Medicinal and Food Homologous Health Product Sales 2020-2031
1.4.3 Global Medicinal and Food Homologous Health Product Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Medicinal and Food Homologous Health Product Market Competition by Manufacturers
2.1 Global Medicinal and Food Homologous Health Product Sales Market Share by Manufacturers (2020-2025)
2.2 Global Medicinal and Food Homologous Health Product Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Medicinal and Food Homologous Health Product Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Medicinal and Food Homologous Health Product, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medicinal and Food Homologous Health Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medicinal and Food Homologous Health Product, Product Type & Application
2.7 Global Key Manufacturers of Medicinal and Food Homologous Health Product, Date of Enter into This Industry
2.8 Global Medicinal and Food Homologous Health Product Market Competitive Situation and Trends
2.8.1 Global Medicinal and Food Homologous Health Product Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Medicinal and Food Homologous Health Product Players Market Share by Revenue
2.8.3 Global Medicinal and Food Homologous Health Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medicinal and Food Homologous Health Product Market Scenario by Region
3.1 Global Medicinal and Food Homologous Health Product Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Medicinal and Food Homologous Health Product Sales by Region: 2020-2031
3.2.1 Global Medicinal and Food Homologous Health Product Sales by Region: 2020-2025
3.2.2 Global Medicinal and Food Homologous Health Product Sales by Region: 2026-2031
3.3 Global Medicinal and Food Homologous Health Product Revenue by Region: 2020-2031
3.3.1 Global Medicinal and Food Homologous Health Product Revenue by Region: 2020-2025
3.3.2 Global Medicinal and Food Homologous Health Product Revenue by Region: 2026-2031
3.4 North America Medicinal and Food Homologous Health Product Market Facts & Figures by Country
3.4.1 North America Medicinal and Food Homologous Health Product Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Medicinal and Food Homologous Health Product Sales by Country (2020-2031)
3.4.3 North America Medicinal and Food Homologous Health Product Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medicinal and Food Homologous Health Product Market Facts & Figures by Country
3.5.1 Europe Medicinal and Food Homologous Health Product Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Medicinal and Food Homologous Health Product Sales by Country (2020-2031)
3.5.3 Europe Medicinal and Food Homologous Health Product Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medicinal and Food Homologous Health Product Market Facts & Figures by Region
3.6.1 Asia Pacific Medicinal and Food Homologous Health Product Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Medicinal and Food Homologous Health Product Sales by Region (2020-2031)
3.6.3 Asia Pacific Medicinal and Food Homologous Health Product Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medicinal and Food Homologous Health Product Market Facts & Figures by Country
3.7.1 Latin America Medicinal and Food Homologous Health Product Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Medicinal and Food Homologous Health Product Sales by Country (2020-2031)
3.7.3 Latin America Medicinal and Food Homologous Health Product Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medicinal and Food Homologous Health Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Medicinal and Food Homologous Health Product Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Medicinal and Food Homologous Health Product Sales by Country (2020-2031)
3.8.3 Middle East and Africa Medicinal and Food Homologous Health Product Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medicinal and Food Homologous Health Product Sales by Type (2020-2031)
4.1.1 Global Medicinal and Food Homologous Health Product Sales by Type (2020-2025)
4.1.2 Global Medicinal and Food Homologous Health Product Sales by Type (2026-2031)
4.1.3 Global Medicinal and Food Homologous Health Product Sales Market Share by Type (2020-2031)
4.2 Global Medicinal and Food Homologous Health Product Revenue by Type (2020-2031)
4.2.1 Global Medicinal and Food Homologous Health Product Revenue by Type (2020-2025)
4.2.2 Global Medicinal and Food Homologous Health Product Revenue by Type (2026-2031)
4.2.3 Global Medicinal and Food Homologous Health Product Revenue Market Share by Type (2020-2031)
4.3 Global Medicinal and Food Homologous Health Product Price by Type (2020-2031)
5 Segment by Application
5.1 Global Medicinal and Food Homologous Health Product Sales by Application (2020-2031)
5.1.1 Global Medicinal and Food Homologous Health Product Sales by Application (2020-2025)
5.1.2 Global Medicinal and Food Homologous Health Product Sales by Application (2026-2031)
5.1.3 Global Medicinal and Food Homologous Health Product Sales Market Share by Application (2020-2031)
5.2 Global Medicinal and Food Homologous Health Product Revenue by Application (2020-2031)
5.2.1 Global Medicinal and Food Homologous Health Product Revenue by Application (2020-2025)
5.2.2 Global Medicinal and Food Homologous Health Product Revenue by Application (2026-2031)
5.2.3 Global Medicinal and Food Homologous Health Product Revenue Market Share by Application (2020-2031)
5.3 Global Medicinal and Food Homologous Health Product Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Isabel Healthcare
6.1.1 Isabel Healthcare Company Information
6.1.2 Isabel Healthcare Description and Business Overview
6.1.3 Isabel Healthcare Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Isabel Healthcare Medicinal and Food Homologous Health Product Product Portfolio
6.1.5 Isabel Healthcare Recent Developments/Updates
6.2 Nature's Way
6.2.1 Nature's Way Company Information
6.2.2 Nature's Way Description and Business Overview
6.2.3 Nature's Way Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nature's Way Medicinal and Food Homologous Health Product Product Portfolio
6.2.5 Nature's Way Recent Developments/Updates
6.3 Beijing Tongrentang Co., Ltd.
6.3.1 Beijing Tongrentang Co., Ltd. Company Information
6.3.2 Beijing Tongrentang Co., Ltd. Description and Business Overview
6.3.3 Beijing Tongrentang Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beijing Tongrentang Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.3.5 Beijing Tongrentang Co., Ltd. Recent Developments/Updates
6.4 Dong-E-E-Jiao Co., Ltd.
6.4.1 Dong-E-E-Jiao Co., Ltd. Company Information
6.4.2 Dong-E-E-Jiao Co., Ltd. Description and Business Overview
6.4.3 Dong-E-E-Jiao Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Dong-E-E-Jiao Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.4.5 Dong-E-E-Jiao Co., Ltd. Recent Developments/Updates
6.5 By-health Co., Ltd.
6.5.1 By-health Co., Ltd. Company Information
6.5.2 By-health Co., Ltd. Description and Business Overview
6.5.3 By-health Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2020-2025)
6.5.4 By-health Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.5.5 By-health Co., Ltd. Recent Developments/Updates
6.6 Zhejiang Renzhichu Health Industry Co., Ltd.
6.6.1 Zhejiang Renzhichu Health Industry Co., Ltd. Company Information
6.6.2 Zhejiang Renzhichu Health Industry Co., Ltd. Description and Business Overview
6.6.3 Zhejiang Renzhichu Health Industry Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zhejiang Renzhichu Health Industry Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.6.5 Zhejiang Renzhichu Health Industry Co., Ltd. Recent Developments/Updates
6.7 Hanguk Insam Gongsa
6.7.1 Hanguk Insam Gongsa Company Information
6.7.2 Hanguk Insam Gongsa Description and Business Overview
6.7.3 Hanguk Insam Gongsa Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hanguk Insam Gongsa Medicinal and Food Homologous Health Product Product Portfolio
6.7.5 Hanguk Insam Gongsa Recent Developments/Updates
6.8 Shandong Gubentang Health Industry Development Group Co., Ltd.
6.8.1 Shandong Gubentang Health Industry Development Group Co., Ltd. Company Information
6.8.2 Shandong Gubentang Health Industry Development Group Co., Ltd. Description and Business Overview
6.8.3 Shandong Gubentang Health Industry Development Group Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shandong Gubentang Health Industry Development Group Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.8.5 Shandong Gubentang Health Industry Development Group Co., Ltd. Recent Developments/Updates
6.9 Renhe Pharmacy Co., Ltd.
6.9.1 Renhe Pharmacy Co., Ltd. Company Information
6.9.2 Renhe Pharmacy Co., Ltd. Description and Business Overview
6.9.3 Renhe Pharmacy Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Renhe Pharmacy Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.9.5 Renhe Pharmacy Co., Ltd. Recent Developments/Updates
6.10 Ningxia Qilixiang Medlar Co., Ltd.
6.10.1 Ningxia Qilixiang Medlar Co., Ltd. Company Information
6.10.2 Ningxia Qilixiang Medlar Co., Ltd. Description and Business Overview
6.10.3 Ningxia Qilixiang Medlar Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ningxia Qilixiang Medlar Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.10.5 Ningxia Qilixiang Medlar Co., Ltd. Recent Developments/Updates
6.11 Nu Skin Enterprises
6.11.1 Nu Skin Enterprises Company Information
6.11.2 Nu Skin Enterprises Description and Business Overview
6.11.3 Nu Skin Enterprises Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nu Skin Enterprises Medicinal and Food Homologous Health Product Product Portfolio
6.11.5 Nu Skin Enterprises Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medicinal and Food Homologous Health Product Industry Chain Analysis
7.2 Medicinal and Food Homologous Health Product Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medicinal and Food Homologous Health Product Production Mode & Process Analysis
7.4 Medicinal and Food Homologous Health Product Sales and Marketing
7.4.1 Medicinal and Food Homologous Health Product Sales Channels
7.4.2 Medicinal and Food Homologous Health Product Distributors
7.5 Medicinal and Food Homologous Health Product Customer Analysis
8 Medicinal and Food Homologous Health Product Market Dynamics
8.1 Medicinal and Food Homologous Health Product Industry Trends
8.2 Medicinal and Food Homologous Health Product Market Drivers
8.3 Medicinal and Food Homologous Health Product Market Challenges
8.4 Medicinal and Food Homologous Health Product Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Medicinal and Food Homologous Health Product Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Medicinal and Food Homologous Health Product Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Medicinal and Food Homologous Health Product Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Medicinal and Food Homologous Health Product Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Medicinal and Food Homologous Health Product Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Medicinal and Food Homologous Health Product Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Medicinal and Food Homologous Health Product Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Medicinal and Food Homologous Health Product Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Medicinal and Food Homologous Health Product, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Medicinal and Food Homologous Health Product, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Medicinal and Food Homologous Health Product, Product Type & Application
 Table 12. Global Key Manufacturers of Medicinal and Food Homologous Health Product, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Medicinal and Food Homologous Health Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicinal and Food Homologous Health Product as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Medicinal and Food Homologous Health Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Medicinal and Food Homologous Health Product Sales by Region (2020-2025) & (K Units)
 Table 18. Global Medicinal and Food Homologous Health Product Sales Market Share by Region (2020-2025)
 Table 19. Global Medicinal and Food Homologous Health Product Sales by Region (2026-2031) & (K Units)
 Table 20. Global Medicinal and Food Homologous Health Product Sales Market Share by Region (2026-2031)
 Table 21. Global Medicinal and Food Homologous Health Product Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Medicinal and Food Homologous Health Product Revenue Market Share by Region (2020-2025)
 Table 23. Global Medicinal and Food Homologous Health Product Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Medicinal and Food Homologous Health Product Revenue Market Share by Region (2026-2031)
 Table 25. North America Medicinal and Food Homologous Health Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Medicinal and Food Homologous Health Product Sales by Country (2020-2025) & (K Units)
 Table 27. North America Medicinal and Food Homologous Health Product Sales by Country (2026-2031) & (K Units)
 Table 28. North America Medicinal and Food Homologous Health Product Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Medicinal and Food Homologous Health Product Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Medicinal and Food Homologous Health Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Medicinal and Food Homologous Health Product Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Medicinal and Food Homologous Health Product Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Medicinal and Food Homologous Health Product Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Medicinal and Food Homologous Health Product Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Medicinal and Food Homologous Health Product Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Medicinal and Food Homologous Health Product Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Medicinal and Food Homologous Health Product Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Medicinal and Food Homologous Health Product Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Medicinal and Food Homologous Health Product Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Medicinal and Food Homologous Health Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Medicinal and Food Homologous Health Product Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Medicinal and Food Homologous Health Product Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Medicinal and Food Homologous Health Product Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Medicinal and Food Homologous Health Product Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Medicinal and Food Homologous Health Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Medicinal and Food Homologous Health Product Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Medicinal and Food Homologous Health Product Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Medicinal and Food Homologous Health Product Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Medicinal and Food Homologous Health Product Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Medicinal and Food Homologous Health Product Sales (K Units) by Type (2020-2025)
 Table 51. Global Medicinal and Food Homologous Health Product Sales (K Units) by Type (2026-2031)
 Table 52. Global Medicinal and Food Homologous Health Product Sales Market Share by Type (2020-2025)
 Table 53. Global Medicinal and Food Homologous Health Product Sales Market Share by Type (2026-2031)
 Table 54. Global Medicinal and Food Homologous Health Product Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Medicinal and Food Homologous Health Product Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Medicinal and Food Homologous Health Product Revenue Market Share by Type (2020-2025)
 Table 57. Global Medicinal and Food Homologous Health Product Revenue Market Share by Type (2026-2031)
 Table 58. Global Medicinal and Food Homologous Health Product Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Medicinal and Food Homologous Health Product Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Medicinal and Food Homologous Health Product Sales (K Units) by Application (2020-2025)
 Table 61. Global Medicinal and Food Homologous Health Product Sales (K Units) by Application (2026-2031)
 Table 62. Global Medicinal and Food Homologous Health Product Sales Market Share by Application (2020-2025)
 Table 63. Global Medicinal and Food Homologous Health Product Sales Market Share by Application (2026-2031)
 Table 64. Global Medicinal and Food Homologous Health Product Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Medicinal and Food Homologous Health Product Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Medicinal and Food Homologous Health Product Revenue Market Share by Application (2020-2025)
 Table 67. Global Medicinal and Food Homologous Health Product Revenue Market Share by Application (2026-2031)
 Table 68. Global Medicinal and Food Homologous Health Product Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Medicinal and Food Homologous Health Product Price (US$/Unit) by Application (2026-2031)
 Table 70. Isabel Healthcare Company Information
 Table 71. Isabel Healthcare Description and Business Overview
 Table 72. Isabel Healthcare Medicinal and Food Homologous Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Isabel Healthcare Medicinal and Food Homologous Health Product Product
 Table 74. Isabel Healthcare Recent Developments/Updates
 Table 75. Nature's Way Company Information
 Table 76. Nature's Way Description and Business Overview
 Table 77. Nature's Way Medicinal and Food Homologous Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Nature's Way Medicinal and Food Homologous Health Product Product
 Table 79. Nature's Way Recent Developments/Updates
 Table 80. Beijing Tongrentang Co., Ltd. Company Information
 Table 81. Beijing Tongrentang Co., Ltd. Description and Business Overview
 Table 82. Beijing Tongrentang Co., Ltd. Medicinal and Food Homologous Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Beijing Tongrentang Co., Ltd. Medicinal and Food Homologous Health Product Product
 Table 84. Beijing Tongrentang Co., Ltd. Recent Developments/Updates
 Table 85. Dong-E-E-Jiao Co., Ltd. Company Information
 Table 86. Dong-E-E-Jiao Co., Ltd. Description and Business Overview
 Table 87. Dong-E-E-Jiao Co., Ltd. Medicinal and Food Homologous Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Dong-E-E-Jiao Co., Ltd. Medicinal and Food Homologous Health Product Product
 Table 89. Dong-E-E-Jiao Co., Ltd. Recent Developments/Updates
 Table 90. By-health Co., Ltd. Company Information
 Table 91. By-health Co., Ltd. Description and Business Overview
 Table 92. By-health Co., Ltd. Medicinal and Food Homologous Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. By-health Co., Ltd. Medicinal and Food Homologous Health Product Product
 Table 94. By-health Co., Ltd. Recent Developments/Updates
 Table 95. Zhejiang Renzhichu Health Industry Co., Ltd. Company Information
 Table 96. Zhejiang Renzhichu Health Industry Co., Ltd. Description and Business Overview
 Table 97. Zhejiang Renzhichu Health Industry Co., Ltd. Medicinal and Food Homologous Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Zhejiang Renzhichu Health Industry Co., Ltd. Medicinal and Food Homologous Health Product Product
 Table 99. Zhejiang Renzhichu Health Industry Co., Ltd. Recent Developments/Updates
 Table 100. Hanguk Insam Gongsa Company Information
 Table 101. Hanguk Insam Gongsa Description and Business Overview
 Table 102. Hanguk Insam Gongsa Medicinal and Food Homologous Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Hanguk Insam Gongsa Medicinal and Food Homologous Health Product Product
 Table 104. Hanguk Insam Gongsa Recent Developments/Updates
 Table 105. Shandong Gubentang Health Industry Development Group Co., Ltd. Company Information
 Table 106. Shandong Gubentang Health Industry Development Group Co., Ltd. Description and Business Overview
 Table 107. Shandong Gubentang Health Industry Development Group Co., Ltd. Medicinal and Food Homologous Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Shandong Gubentang Health Industry Development Group Co., Ltd. Medicinal and Food Homologous Health Product Product
 Table 109. Shandong Gubentang Health Industry Development Group Co., Ltd. Recent Developments/Updates
 Table 110. Renhe Pharmacy Co., Ltd. Company Information
 Table 111. Renhe Pharmacy Co., Ltd. Description and Business Overview
 Table 112. Renhe Pharmacy Co., Ltd. Medicinal and Food Homologous Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Renhe Pharmacy Co., Ltd. Medicinal and Food Homologous Health Product Product
 Table 114. Renhe Pharmacy Co., Ltd. Recent Developments/Updates
 Table 115. Ningxia Qilixiang Medlar Co., Ltd. Company Information
 Table 116. Ningxia Qilixiang Medlar Co., Ltd. Description and Business Overview
 Table 117. Ningxia Qilixiang Medlar Co., Ltd. Medicinal and Food Homologous Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ningxia Qilixiang Medlar Co., Ltd. Medicinal and Food Homologous Health Product Product
 Table 119. Ningxia Qilixiang Medlar Co., Ltd. Recent Developments/Updates
 Table 120. Nu Skin Enterprises Company Information
 Table 121. Nu Skin Enterprises Description and Business Overview
 Table 122. Nu Skin Enterprises Medicinal and Food Homologous Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Nu Skin Enterprises Medicinal and Food Homologous Health Product Product
 Table 124. Nu Skin Enterprises Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Medicinal and Food Homologous Health Product Distributors List
 Table 128. Medicinal and Food Homologous Health Product Customers List
 Table 129. Medicinal and Food Homologous Health Product Market Trends
 Table 130. Medicinal and Food Homologous Health Product Market Drivers
 Table 131. Medicinal and Food Homologous Health Product Market Challenges
 Table 132. Medicinal and Food Homologous Health Product Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medicinal and Food Homologous Health Product
 Figure 2. Global Medicinal and Food Homologous Health Product Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Medicinal and Food Homologous Health Product Market Share by Type: 2024 & 2031
 Figure 4. Oral Beauty Product Picture
 Figure 5. Liver Protection Product Picture
 Figure 6. Sleep Aid Product Picture
 Figure 7. Other Types Product Picture
 Figure 8. Global Medicinal and Food Homologous Health Product Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Medicinal and Food Homologous Health Product Market Share by Application: 2024 & 2031
 Figure 10. Health Maintenance
 Figure 11. Nutritional Supplement
 Figure 12. Heart and Brain Health
 Figure 13. Joint Health
 Figure 14. Others
 Figure 15. Global Medicinal and Food Homologous Health Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Medicinal and Food Homologous Health Product Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Medicinal and Food Homologous Health Product Sales (2020-2031) & (K Units)
 Figure 18. Global Medicinal and Food Homologous Health Product Average Price (US$/Unit) & (2020-2031)
 Figure 19. Medicinal and Food Homologous Health Product Report Years Considered
 Figure 20. Medicinal and Food Homologous Health Product Sales Share by Manufacturers in 2024
 Figure 21. Global Medicinal and Food Homologous Health Product Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Medicinal and Food Homologous Health Product Players: Market Share by Revenue in Medicinal and Food Homologous Health Product in 2024
 Figure 23. Medicinal and Food Homologous Health Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Medicinal and Food Homologous Health Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Medicinal and Food Homologous Health Product Sales Market Share by Country (2020-2031)
 Figure 26. North America Medicinal and Food Homologous Health Product Revenue Market Share by Country (2020-2031)
 Figure 27. United States Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Medicinal and Food Homologous Health Product Sales Market Share by Country (2020-2031)
 Figure 30. Europe Medicinal and Food Homologous Health Product Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Medicinal and Food Homologous Health Product Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Medicinal and Food Homologous Health Product Revenue Market Share by Region (2020-2031)
 Figure 38. China Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Medicinal and Food Homologous Health Product Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Medicinal and Food Homologous Health Product Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Medicinal and Food Homologous Health Product Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Medicinal and Food Homologous Health Product Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Medicinal and Food Homologous Health Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Medicinal and Food Homologous Health Product by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Medicinal and Food Homologous Health Product by Type (2020-2031)
 Figure 57. Global Medicinal and Food Homologous Health Product Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Medicinal and Food Homologous Health Product by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Medicinal and Food Homologous Health Product by Application (2020-2031)
 Figure 60. Global Medicinal and Food Homologous Health Product Price (US$/Unit) by Application (2020-2031)
 Figure 61. Medicinal and Food Homologous Health Product Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure